Health authorities in the UK have issued a stark warning about counterfeit versions of the popular weight-loss injection Ozempic circulating in the country. The Medicines and Healthcare products Regulatory Agency (MHRA) reports a worrying rise in fake versions of the diabetes drug, which has gained popularity for its weight-loss effects.
Dangerous Counterfeits in Circulation
The MHRA has identified fake Ozempic pens containing insulin rather than the proper semaglutide compound. These counterfeit products pose serious health risks, with several hospitalisations already reported. "These fake medicines could contain harmful substances," warned Dr. Alison Cave, MHRA Chief Safety Officer.
How to Spot Fake Ozempic
Officials advise consumers to watch for these warning signs:
- Unusually low prices (below NHS prescription costs)
- No requirement for prescription
- Poor quality packaging or labelling errors
- Products sold through social media or unregulated websites
Official Supply Shortages Fuel Black Market
The warning comes amid ongoing shortages of genuine Ozempic, creating opportunities for criminals to exploit desperate consumers. Novo Nordisk, the manufacturer, has struggled to meet global demand since the drug went viral for its weight-loss benefits.
Medical professionals stress that Ozempic should only be used under proper supervision. "These are prescription medicines for a reason," said Dr. Cave. "Self-medicating with unregulated products can have dangerous consequences."
What to Do If You've Used Suspect Products
The MHRA urges anyone who experiences adverse effects from suspected fake Ozempic to:
- Stop using the product immediately
- Seek medical advice
- Report the incident via the Yellow Card scheme
Authorities are working closely with border forces and online platforms to intercept counterfeit shipments and remove illegal listings.
